Literature DB >> 11374874

Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin.

H Zoellner1, J Y Hou, T Hochgrebe, A Poljak, M W Duncan, J Golding, T Henderson, G Lynch.   

Abstract

Albumin is the major transport protein in blood and intramolecular movement contributes to this function. Nonenzymatic glycosylation (NEG) of albumin occurs in diabetes and, in this study, fluorometric methods were used to determine the effect of increasing levels of NEG upon intramolecular movement in human serum albumin. Low levels of NEG significantly reduced and left-shifted Trp fluorescence, reduced quenching by acrylamide and inhibited penetration of bis-ANS, while these changes became only modestly more pronounced at higher levels of NEG. Mass spectrometry of tryptic and CNBr NEG-HSA fragments identified potential glycosylation sites and demonstrated only late glycosylation of the C- and N-terminal regions of the protein. Similar changes in diabetes may contribute to altered transport function in these patients. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11374874     DOI: 10.1006/bbrc.2001.4924

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Glycated albumin: from biochemistry and laboratory medicine to clinical practice.

Authors:  Elena Dozio; Nicola Di Gaetano; Peter Findeisen; Massimiliano Marco Corsi Romanelli
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

2.  Antioxidant capacity and structural changes of human serum albumin from patients in advanced stages of diabetic nephropathy and the effect of the dialysis.

Authors:  Marisol Rosas-Díaz; Menandro Camarillo-Cadena; Andrés Hernández-Arana; Eva Ramón-Gallegos; Rafael Medina-Navarro
Journal:  Mol Cell Biochem       Date:  2015-03-11       Impact factor: 3.396

Review 3.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

4.  Physicochemical characterization of carbamylated human serum albumin: an in vitro study.

Authors:  Asim Badar; Zarina Arif; Shireen Naaz Islam; Khursheed Alam
Journal:  RSC Adv       Date:  2019-11-11       Impact factor: 4.036

Review 5.  Review: Glycation of human serum albumin.

Authors:  Jeanethe Anguizola; Ryan Matsuda; Omar S Barnaby; K S Hoy; Chunling Wa; Erin DeBolt; Michelle Koke; David S Hage
Journal:  Clin Chim Acta       Date:  2013-07-24       Impact factor: 3.786

6.  Investigation of non-enzymatic glycosylation of human serum albumin using ion trap-time of flight mass spectrometry.

Authors:  Xue Bai; Zhangjie Wang; Chengcai Huang; Zhe Wang; Lianli Chi
Journal:  Molecules       Date:  2012-07-25       Impact factor: 4.411

7.  The anti-apoptotic activity of albumin for endothelium is inhibited by advanced glycation end products restricting intramolecular movement.

Authors:  Hans Zoellner; Salman Siddiqui; Elizabeth Kelly; Heather Medbury
Journal:  Cell Mol Biol Lett       Date:  2009-05-30       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.